Literature DB >> 3336270

Endogenous digoxin-like immunoreactivity in blood is increased during prolonged strenuous exercise.

R Valdes1, J M Hagberg, T E Vaughan, B W Lau, D R Seals, A A Ehsani.   

Abstract

Digoxin-like immunoreactive factors (DLIFs) in serum may represent endogenous cardiotropic agents. We determined if blood levels of these endogenous factors changed during prolonged strenuous exercise. Total and loosely protein-bound (LPB) DLIF were measured by radioimmunoassay in the serum of nine healthy subjects during prolonged exercise to exhaustion. Mean total and LPB serum levels of DLIF increased by 72% (580 to 945 pg/mL) and 63% (53 to 91 pg/mL) over baseline values in digoxin equivalents (p less than 0.01), respectively, after three hours of exercise at 70% of VO2max. The prevalent serum nonesterified fatty acids (arachidonic, linoleic, oleic, palmitic, and stearic acids) as well as hydrocortisone did not account for the observed elevations in DLIF. Percent left ventricular fractional shortening (%FS) and mean velocity of left ventricular circumferential fiber shortening (mVCF) measured echocardiographically were lower (-18.0% and -16.4%, respectively, p less than 0.05) after exercise as compared to prior to exercise. Cardiac left ventricular dysfunction as measured by %FS did correlate with blood levels of DLIF (r = -0.680, p less than 0.02). These observations may suggest a relationship between serum levels of DLIF and cardiac fatigue.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3336270     DOI: 10.1016/0024-3205(88)90629-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

Review 1.  Endogenous factors with immunological and biological activity similar to cardiac glycosides: biochemical and pathophysiological implications.

Authors:  A Clerico; G Mariani
Journal:  J Endocrinol Invest       Date:  1992-05       Impact factor: 4.256

2.  Total digoxin-like immunoreactive factor(s) in healthy population, uncomplicated term pregnancies and neonates.

Authors:  N Krivoy; P Jakobi; E Paldi; G Alroy
Journal:  J Endocrinol Invest       Date:  1990-01       Impact factor: 4.256

Review 3.  Role of endogenous ouabain in the etiology of bipolar disorder.

Authors:  Rif S El-Mallakh; Yonglin Gao; Pan You
Journal:  Int J Bipolar Disord       Date:  2021-02-01

Review 4.  Endogenous Cardiac Steroids in Bipolar Disorder: State of the Art.

Authors:  Rif S El-Mallakh; Vishnu Priya Sampath; Noa Horesh; David Lichtstein
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.